Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TFEC |
| Upstream (Parents) |
|---|
| (<<) BHLHE41 → TFEC |
| (<<) TCF4 → TFEC |
| (<<) EGR2 → TFEC |
| (<<) MAFB → TFEC |
| (<<) RARB → TFEC |
| (<<) HCLS1 → TFEC |
| Downstream (Children) |
|---|
| TFEC → ATOH1 (>>) |
| TFEC → HNF4A (>>) |
| TFEC → ARNT2 (>>) |
| TFEC → NFKB2 (>>) |
| TFEC → NR4A3 (>>) |
| TFEC → TSC22D2 (>>) |
| TFEC → ZNF132 (>>) |
| TFEC → FOXH1 (>>) |
| TFEC → LMX1B (>>) |
| TFEC → TRIM22 (>>) |
| TFEC → FLI1 (>>) |
| TFEC → SPI1 (>>) |
| TFEC → MEIS1 (>>) |
| TFEC → ZEB2 (>>) |
| TFEC → FOXA2 (>>) |
| TFEC → BATF3 (>>) |
| TFEC → VAV1 (>>) |
| TFEC → HOXB2 (>>) |
| TFEC → RUNX3 (>>) |
| TFEC → NR2C1 (>>) |
